/Cencora%20Inc_%20HQ-by%20JHVEPhoto%20via%20iStock.jpg)
Conshohocken, Pennsylvania-based Cencora, Inc. (COR) is a pharmaceutical sourcing and distribution company. With a market cap of $44.6 billion, Cencora operates through U.S. Healthcare Solutions and International Healthcare Solutions segments, providing pharmaceutical supplies, healthcare products, and services to various healthcare providers. It is expected to announce its Q3 earnings, before the market opens on Wednesday, July 31.
Ahead of the event, analysts expect Cencora to report a profit of $3.18 per share, up 8.9% from $2.92 per share reported in the year-ago quarter. The company has consistently surpassed Wall Street’s EPS estimates over the past four quarters. Its EPS for the last reported quarter grew 8.6% to $3.80, exceeding the consensus estimates by 4.1%.